Protect Pharmaceutical (Protect Pharmaceutical) EV-to-EBITDA : -3,303.00 (As of May. 12, 2024)

Protect Pharmaceutical EV-to-EBITDA Chart

Protect Pharmaceutical Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
EV-to-EBITDA		Get a 7-Day Free Trial				-83.29	-239.97	-21.48	-26.43	-8.60

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EV-to-EBITDA	Get a 7-Day Free Trial															-8.77	-6.97	-8.60	-8.23	-1,065.18

Competitive Comparison of Protect Pharmaceutical's EV-to-EBITDA

For the Conglomerates subindustry, Protect Pharmaceutical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protect Pharmaceutical's EV-to-EBITDA Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-EBITDA falls into.

Protect Pharmaceutical EV-to-EBITDA Calculation

Protect Pharmaceutical's EV-to-EBITDA for today is calculated as:

Protect Pharmaceutical's current Enterprise Value is $3.30 Mil.
Protect Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical  (OTCPK:PRTT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Protect Pharmaceutical's PE Ratio for today is calculated as:

Protect Pharmaceutical's share price for today is $2.92.
Protect Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Protect Pharmaceutical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Protect Pharmaceutical (Protect Pharmaceutical) Business Description